Pharma

Lallemand Pharma AG, based in Massagno (Switzerland) is in charge of the business and possesses the intellectual property rights of an immunostimulant drug indicated in the prevention of respiratory infections known as PMBL® sublingual tablets. The company is dedicated to clinical studies, registrations, marketing and sales of the PMBL® drug. The original PMBL® active pharmaceutical ingredient is produced by the Lallemand GMP Pharma facility.

Thanks to its important distributor’s network consisting of leading international pharmaceutical companies, Lallemand Pharma markets all around the world drugs containing PMBL® under different brands: Ismigen®, Immubron®, Respibron®, PIR-05®, and Pulmigen®.